Saturday 17 October 2026
Export UHS’s income statement to Excel — free account
Universal Health Services, Inc.
UHS Healthcare Medical Care Facilities
Universal Health Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $17.4 billion, up 9.71% from fiscal 2024. In the quarter to June 2026, revenue grew 8.27%, EPS grew 9.47%, free cash flow fell 23.8% and total debt rose 5.87%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten.
185.10
2.26
−1.21%
Follow UHS
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
9.29 | 10.44 | 15.10 | 15.43 | 10.81 | 12.41 | 15.68 | 13.99 | 14.71 | 14.78 |
Piotroski F-Score |
8 | 8 | 9 | 7 | 4 | 7 | 7 | 5 | 7 | 6 |
P/S ratio |
0.80 | 0.75 | 0.76 | 0.78 | 0.85 | 1.01 | 1.12 | 1.01 | 1.06 | 1.06 |
Altman Z-Score |
3.29 | 3.17 | 2.87 | 2.79 | 2.97 | 2.95 | 3.32 | 3.20 | 3.19 | 3.15 |
Altman Z″-Score (non-manufacturers) |
3.55 | 3.63 | 3.36 | 3.21 | 3.43 | 3.65 | 3.52 | 3.65 | 3.32 | 3.46 |
P/FCF ratio |
16.32 | 10.63 | 20.66 | 39.80 | 381.63 | 7.18 | 15.83 | 17.83 | 16.02 | 13.09 |
Beneish M-Score |
(2.45) | (2.77) | (2.57) | (2.50) | (2.42) | (2.90) | (2.68) | (2.67) | (2.65) | (2.69) |
P/Operating CF |
24.12 | 18.14 | 23.97 | 35.07 | 33.23 | 82.36 | 38.20 | 33.42 | 29.98 | 52.57 |
Dividend Safety Score |
88 | — | — | — | — | — | — | — | — | — |
P/B ratio |
1.89 | 1.77 | 1.75 | 1.75 | 1.73 | 1.83 | 2.28 | 1.99 | 2.19 | 2.26 |
Price to Tangible BV |
4.14 | 4.24 | 4.79 | 5.07 | 4.80 | 4.64 | 7.45 | 6.71 | 9.02 | 12.75 |
EV/Sales |
1.06 | 1.03 | 1.09 | 1.13 | 1.17 | 1.24 | 1.46 | 1.37 | 1.44 | 1.48 |
EV/EBITDA |
7.07 | 7.20 | 8.97 | 9.54 | 7.79 | 7.67 | 9.76 | 9.07 | 8.69 | 8.52 |
EV/Operating CF |
9.91 | 7.90 | 12.33 | 15.19 | 16.72 | 6.07 | 11.58 | 11.58 | 12.04 | 10.85 |
EV/FCF |
21.76 | 14.53 | 29.80 | 57.75 | 526.98 | 8.80 | 20.71 | 24.21 | 21.77 | 18.27 |
Quick Ratio |
0.85 | 1.04 | 1.17 | 1.11 | 0.94 | 1.19 | 1.04 | 1.11 | 0.85 | 1.12 |
Current Ratio |
1.05 | 1.27 | 1.40 | 1.33 | 1.14 | 1.32 | 1.23 | 1.34 | 0.97 | 1.28 |
Net Debt/EBITDA |
1.77 | 1.93 | 2.75 | 2.97 | 2.15 | 1.41 | 2.30 | 2.39 | 2.29 | 2.42 |
Debt/Assets |
30.61% | 31.13% | 35.17% | 35.63% | 32.00% | 28.61% | 34.15% | 35.49% | 37.54% | 40.09% |
Debt/Equity |
0.65 | 0.67 | 0.79 | 0.81 | 0.68 | 0.60 | 0.71 | 0.73 | 0.80 | 0.90 |
Asset Turnover |
1.16 | 1.11 | 1.04 | 1.01 | 0.95 | 0.92 | 0.99 | 0.98 | 0.99 | 0.98 |
Operating CF/Net income |
1.25 | 1.81 | 1.77 | 1.48 | 0.89 | 2.51 | 1.77 | 1.64 | 1.66 | 1.90 |
Capex/Depreciation |
(1.64) | (1.61) | (1.31) | (1.26) | (1.60) | (1.43) | (1.29) | (1.47) | (1.24) | (1.30) |
Interest Coverage |
12.78 | 9.04 | 5.69 | 7.91 | 16.29 | 12.78 | 7.47 | 7.58 | 8.82 | 10.25 |
| 21.14% | 17.64% | 11.80% | 11.10% | 15.75% | 15.71% | 14.72% | 14.81% | 15.59% | 15.77% | |
| 9.93% | 8.03% | 5.23% | 5.08% | 7.46% | 7.48% | 7.09% | 7.07% | 7.13% | 7.05% | |
ROIC |
10.43% | 9.45% | 6.68% | 5.88% | 8.30% | 9.40% | 8.00% | 7.85% | 8.87% | 9.21% |
Return on Tangible Assets |
20.75% | 15.91% | 10.36% | 10.32% | 16.11% | 15.24% | 15.14% | 14.59% | 16.63% | 14.96% |
Average Days of Receivables |
54.70 | 50.22 | 57.20 | 54.96 | 50.43 | 54.60 | 50.07 | 51.16 | 52.63 | 53.80 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
46.56% | 47.50% | 49.77% | 50.47% | 48.76% | 48.56% | 49.12% | 48.78% | 47.85% | 46.95% |
Intangible Assets out of Total Assets |
0.26 | 0.27 | 0.28 | 0.29 | 0.30 | 0.29 | 0.33 | 0.34 | 0.36 | 0.37 |
Share Based Compensation of Revenue |
0.55% | 0.63% | 0.61% | 0.64% | 0.58% | 0.57% | 0.61% | 0.62% | 0.55% | 0.49% |
Graham Net Nets |
(0.34) | (0.41) | (0.46) | (0.48) | (0.43) | (0.32) | (0.33) | (0.36) | (0.35) | (0.39) |
Graham Number |
246.89 | 197.99 | 144.35 | 130.24 | 142.29 | 136.98 | 113.75 | 104.80 | 96.64 | 87.65 |
Earnings Yield |
10.77% | 9.58% | 6.62% | 6.48% | 9.25% | 8.06% | 6.38% | 7.15% | 6.80% | 6.77% |
Free Cash Flow Yield |
6.13% | 9.41% | 4.84% | 2.51% | 0.26% | 13.93% | 6.32% | 5.61% | 6.24% | 7.64% |
Revenue per Share |
273.11 | 237.82 | 206.03 | 183.26 | 153.20 | 135.89 | 128.19 | 115.49 | 108.83 | 100.47 |
Operating CF per Share |
29.32 | 31.06 | 18.29 | 13.62 | 10.71 | 27.75 | 16.21 | 13.67 | 13.04 | 13.72 |
Capex per Share |
(15.97) | (14.18) | (10.72) | (10.04) | (10.37) | (8.60) | (7.14) | (7.13) | (5.83) | (5.57) |
Free Cash Flow per Share |
13.36 | 16.88 | 7.57 | 3.58 | 0.34 | 19.15 | 9.06 | 6.54 | 7.21 | 8.15 |
Cash per Share |
2.17 | 1.89 | 1.72 | 1.41 | 1.40 | 14.40 | 0.69 | 1.13 | 0.78 | 0.35 |
Shareholders Equity per Share |
115.42 | 101.41 | 89.39 | 81.59 | 75.05 | 75.26 | 62.85 | 58.60 | 52.81 | 47.30 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
115.42 | 101.41 | 89.39 | 81.59 | 75.05 | 75.26 | 62.85 | 58.60 | 52.81 | 47.30 |
Free Cash Flow |
849.25 | 1,123.29 | 524.74 | 262.02 | 28.04 | 1,628.86 | 804.37 | 609.78 | 690.08 | 792.43 |
Working Capital |
168.31 | 605.88 | 798.00 | 622.92 | 279.45 | 800.83 | 352.54 | 489.06 | (50.03) | 364.00 |
Capital Expenditures |
(1,015.15) | (943.81) | (743.05) | (734.00) | (855.66) | (731.31) | (634.09) | (664.96) | (557.51) | (541.41) |
Net Current Asset Value |
(4,780.89) | (4,903.94) | (4,959.54) | (4,991.50) | (4,636.93) | (3,793.04) | (4,173.44) | (3,861.88) | (3,912.39) | (4,038.84) |
EV/EBIT |
9.27 | 9.70 | 13.30 | 15.08 | 10.84 | 10.55 | 13.70 | 12.56 | 11.74 | 11.30 |
Capex to Sales |
0.06 | 0.06 | 0.05 | 0.05 | 0.07 | 0.06 | 0.06 | 0.06 | 0.05 | 0.06 |
Price to Operating Income |
6.95 | 7.10 | 9.22 | 10.39 | 7.85 | 8.61 | 10.47 | 9.25 | 8.64 | 8.10 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.09 | 0.09 | 0.09 | 0.10 | 0.09 | 0.10 | 0.10 | 0.09 | 0.10 | 0.10 |
Cash ROIC |
6.94% | 9.87% | 4.67% | 2.41% | 0.27% | 14.19% | 8.36% | 6.37% | 7.53% | 9.04% |
Accounts Receivable Turnover |
7.27 | 7.17 | 6.71 | 7.12 | 7.27 | 7.03 | 7.41 | 7.16 | 7.08 | 7.12 |
Accounts Payable Turnover |
2.40 | 2.55 | 2.45 | 2.28 | 2.32 | 2.53 | 2.80 | 2.63 | 2.51 | 2.56 |
Inventory Turnover |
7.32 | 7.25 | 7.04 | 6.93 | 7.19 | 7.35 | 8.12 | 8.22 | 8.45 | 8.54 |
Average Days of Payables |
165.04 | 145.28 | 146.20 | 157.60 | 168.52 | 161.66 | 130.37 | 139.19 | 145.98 | 155.60 |
Days of Inventory on Hand |
51.07 | 50.79 | 51.67 | 54.10 | 52.90 | 53.96 | 46.64 | 46.29 | 44.98 | 44.37 |
Average Receivables |
2,390.09 | 2,208.01 | 2,127.99 | 1,882.18 | 1,737.78 | 1,644.89 | 1,535.38 | 1,505.40 | 1,470.23 | 1,370.99 |
Average Payables |
691.07 | 622.99 | 625.29 | 647.75 | 614.71 | 508.74 | 446.30 | 443.82 | 440.83 | 402.96 |
Average Inventory |
226.53 | 218.96 | 217.75 | 212.68 | 198.63 | 175.15 | 154.05 | 142.19 | 130.77 | 120.70 |
Average Assets |
14,998.67 | 14,218.68 | 13,730.90 | 13,293.87 | 13,285.21 | 12,572.57 | 11,466.87 | 11,013.66 | 10,539.82 | 9,966.62 |
Average Common Equity |
7,044.16 | 6,473.12 | 6,081.03 | 6,079.20 | 6,297.51 | 5,990.42 | 5,522.33 | 5,258.61 | 4,824.52 | 4,453.38 |
Columns are period end dates